Nyxoah
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more
Market Cap & Net Worth: Nyxoah (NYXH)
Nyxoah (NASDAQ:NYXH) has a market capitalization of $134.24 Million ($134.24 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20044 globally and #7314 in its home market, demonstrating a -10.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nyxoah's stock price $3.12 by its total outstanding shares 43026460 (43.03 Million).
Nyxoah Market Cap History: 2021 to 2026
Nyxoah's market capitalization history from 2021 to 2026. Data shows change from $989.61 Million to $134.24 Million (-34.13% CAGR).
Index Memberships
Nyxoah is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #552 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1827 of 3165 |
Weight: Nyxoah's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nyxoah Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nyxoah's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
76.14x
Nyxoah's market cap is 76.14 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $989.61 Million | $852.00K | -$27.62 Million | 1161.51x | N/A |
| 2022 | $214.70 Million | $3.08 Million | -$31.23 Million | 69.62x | N/A |
| 2023 | $199.64 Million | $4.35 Million | -$43.21 Million | 45.92x | N/A |
| 2024 | $344.21 Million | $4.52 Million | -$59.24 Million | 76.14x | N/A |
Competitor Companies of NYXH by Market Capitalization
Companies near Nyxoah in the global market cap rankings as of March 19, 2026.
Key companies related to Nyxoah by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Nyxoah Historical Marketcap From 2021 to 2026
Between 2021 and today, Nyxoah's market cap moved from $989.61 Million to $ 134.24 Million, with a yearly change of -34.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $134.24 Million | -32.17% |
| 2025 | $197.92 Million | -42.50% |
| 2024 | $344.21 Million | +72.41% |
| 2023 | $199.64 Million | -7.01% |
| 2022 | $214.70 Million | -78.30% |
| 2021 | $989.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nyxoah was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $134.24 Million USD |
| MoneyControl | $134.24 Million USD |
| MarketWatch | $134.24 Million USD |
| marketcap.company | $134.24 Million USD |
| Reuters | $134.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.